{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:19:18Z","timestamp":1793945958152,"version":"4.8.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Gail C. and Howard Woolley"},{"name":"Wilmer Biostatistics Core","award":["EY01765"],"award-info":[{"award-number":["EY01765"]}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ajo.2018.09.025","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T18:15:07Z","timestamp":1538244907000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Clinical and Ophthalmic Factors Associated With the Severity of Sickle Cell Retinopathy"],"prefix":"10.1016","volume":"197","author":[{"given":"Xiangyun J.","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite O.","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2018.09.025_bib1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in SCD: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.ajo.2018.09.025_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archopht.1971.00990050430006","article-title":"Natural history of untreated proliferative sickle retinopathy","volume":"85","author":"Goldberg","year":"1971","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.025_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bjo.74.3.172","article-title":"Risk factors for proliferative sickle retinopathy","volume":"72","author":"Fox","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.09.025_bib4","first-page":"481","article-title":"The ocular manifestations of sickle-cell disease: a prevalence and natural history study","volume":"90","author":"Clarkson","year":"1992","journal-title":"Trans Am Ophthamol Soc"},{"issue":"9","key":"10.1016\/j.ajo.2018.09.025_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.revmed.2017.01.010","article-title":"Pr\u00e9valence et facteurs de risqu\u00e9 de la r\u00e9tinopathie dr\u00e9panocytaire dans un centre de suivi dr\u00e9panocytaire d\u2019Afrique subsaharienne [Prevalence and risk factors for sickle retinopathy in a sub-Saharan comprehensive Sickle Cell Center]","volume":"38","author":"Demb\u00e9l\u00e9","year":"2017","journal-title":"Rev Med Interne"},{"issue":"11","key":"10.1016\/j.ajo.2018.09.025_bib6","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ophtha.2005.05.026","article-title":"Incidence and natural history of proliferative SCR","volume":"112","author":"Downes","year":"2005","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2018.09.025_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MD.0b013e3182364cba","article-title":"Clinical and laboratory factors associated with the severity of proliferative SCR in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease","volume":"90","author":"Leveziel","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ajo.2018.09.025_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5301\/EJO.2010.5977","article-title":"Ocular manifestations of SCD at the Korle-bu Hospital, Accra, Ghana","volume":"21","author":"Osafo-Kwaako","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.025_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S0004-27492011000300009","article-title":"Altera\u00e7\u00f5es oculares e eletrorretinogr\u00e1ficas na doen\u00e7a falciforme [Ocular and electroretinographic changes in sickle cell disease]","volume":"74","author":"David","year":"2011","journal-title":"Arq Bras Oftalmol"},{"issue":"7","key":"10.1016\/j.ajo.2018.09.025_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jfo.2009.04.010","article-title":"\u00c9tude \u00e9pid\u00e9miologique et facteurs pronostiques de la r\u00e9tinopathie dr\u00e9panocytaire \u00e0 Ouagadougou (Burkina Faso) [Epidemiology and prognostic factors for SCR in Ouagadougou (Burkina Faso)]","volume":"32","author":"Diallo","year":"2009","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.09.025_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.14423\/SMJ.0000000000000525","article-title":"Ophthalmic manifestations of SCD","volume":"109","author":"Scott","year":"2016","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.ajo.2018.09.025_bib12","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1002\/ajh.24680","article-title":"Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia","volume":"92","author":"Aleluia","year":"2017","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.025_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/bjh.12238","article-title":"Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children","volume":"161","author":"Estepp","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ajo.2018.09.025_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOH.0000000000000241","article-title":"New insights into sickle cell disease: mechanisms and investigational therapies","volume":"23","author":"Kato","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.ajo.2018.09.025_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.ajo.2018.09.025_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease. Summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:37:34Z","timestamp":1757597854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418305531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":16,"alternative-id":["S0002939418305531"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.09.025","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Ophthalmic Factors Associated With the Severity of Sickle Cell Retinopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}